aspirin and cgp 39393

aspirin has been researched along with cgp 39393 in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abendschein, DR; Haskel, EJ; Prager, NA; Sobel, BE	1
Belcher, PR; Drossos, GE; Evans, RD; Menys, VC; Noble, MI; Pillai, R; Westaby, S	1
Buchwald, AB; Ebbecke, M; Lüders, S; Munz, DL; Nebendahl, K; Sandrock, D; Unterberg, C; Wiegand, V	1
Lumley, P; Sullivan, AT; White, BP	1
Anderson, JL; Becker, RC; Cannon, CP; Gibson, RS; Haugland, JM; Henry, TD; Kleiman, NS; McCabe, CH; Mueller, HS; Schweiger, MJ	1
Menys, VC	1
Badimon, JJ; Badimon, L; Chesebro, JH; Fallon, JT; Fuster, V; Meyer, BJ	1

Trials

1 trial(s) available for aspirin and cgp 39393

Article	Year
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. Journal of the American College of Cardiology, 1994, Volume: 23, Issue:5 Topics: Adjuvants, Pharmaceutic; Adult; Aged; Aspirin; Coronary Angiography; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pilot Projects; Recombinant Proteins; Survival Rate; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vascular Patency	1994

Article

Year

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.

Journal of the American College of Cardiology, 1994, Volume: 23, Issue:5

Topics: Adjuvants, Pharmaceutic; Adult; Aged; Aspirin; Coronary Angiography; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pilot Projects; Recombinant Proteins; Survival Rate; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vascular Patency

1994

Other Studies

6 other study(ies) available for aspirin and cgp 39393

Article	Year
Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion. Circulation, 1991, Volume: 83, Issue:3 Topics: Animals; Aspirin; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Recombinant Proteins; Recurrence; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator	1991
Macroaggregation of platelets in plasma, as distinct from microaggregation in whole blood (and plasma), as determined using optical aggregometry and platelet counting respectively, is specifically impaired following cardiopulmonary bypass in man. Thrombosis and haemostasis, 1994, Volume: 72, Issue:4 Topics: Aprotinin; Aspirin; Blood; Blood Loss, Surgical; Cardiopulmonary Bypass; Collagen; Hirudins; Humans; Nephelometry and Turbidimetry; Plasma; Platelet Activation; Platelet Aggregation; Platelet Count; Platelet Function Tests; Recombinant Proteins; Ristocetin	1994
Platelet and fibrin deposition on coronary stents in minipigs: effect of hirudin versus heparin. Journal of the American College of Cardiology, 1993, Volume: 21, Issue:1 Topics: Angioplasty, Balloon, Coronary; Animals; Aspirin; Coronary Thrombosis; Dextrans; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Fibrin; Heparin; Hirudin Therapy; Hirudins; Indium Radioisotopes; Male; Platelet Aggregation; Recombinant Proteins; Stents; Swine; Swine, Miniature; Time Factors	1993
Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin. Thrombosis and haemostasis, 1994, Volume: 71, Issue:3 Topics: Anesthesia; Animals; Aspirin; Biphenyl Compounds; Blood Coagulation Tests; Coronary Circulation; Coronary Thrombosis; Dogs; Drug Synergism; Drug Therapy, Combination; Electric Stimulation; Female; Fibrinolytic Agents; Heptanoic Acids; Hirudin Therapy; Hirudins; Male; Platelet Aggregation; Recombinant Proteins; Thrombin; Thromboxane A2; Ticlopidine	1994
Collagen induced human platelet aggregation: serotonin receptor antagonism retards aggregate growth in vitro. Cardiovascular research, 1993, Volume: 27, Issue:11 Topics: Apyrase; Aspirin; Blood Platelets; Collagen; Epinephrine; Hirudins; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Count; Quinolines; Recombinant Proteins; Serotonin; Serotonin Antagonists	1993
Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin. Circulation, 1998, Feb-24, Volume: 97, Issue:7 Topics: Animals; Aspirin; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Heart Diseases; Hematocrit; Heparin; Hirudin Therapy; Hirudins; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Platelet Count; Recombinant Proteins; Swine; Thrombin; Thrombolytic Therapy; Thrombosis	1998